Annual Current Liabilities
$7.45 M
+$3.28 M+78.75%
December 31, 2022
Summary
- As of February 8, 2025, SCPS annual total current liabilities is $7.45 million, with the most recent change of +$3.28 million (+78.75%) on December 31, 2022.
- During the last 3 years, SCPS annual current liabilities has risen by +$6.60 million (+772.37%).
- SCPS annual current liabilities is now at all-time high.
Performance
SCPS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$11.00 M
+$1.69 M+18.13%
June 30, 2023
Summary
- As of February 8, 2025, SCPS quarterly total current liabilities is $11.00 million, with the most recent change of +$1.69 million (+18.13%) on June 30, 2023.
- Over the past year, SCPS quarterly current liabilities has increased by +$5.08 million (+85.86%).
- SCPS quarterly current liabilities is now at all-time high.
Performance
SCPS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SCPS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.8% | +85.9% |
| 3 y3 years | +772.4% | - |
| 5 y5 years | +6597.6% | - |
SCPS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.8% | at high | +163.8% |
| 5 y | 5-year | at high | +772.4% | at high | +1187.5% |
| alltime | all time | at high | +6597.6% | at high | +2925.9% |
Scopus BioPharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $11.00 M(+18.1%) |
| Mar 2023 | - | $9.31 M(+24.9%) |
| Dec 2022 | $7.45 M(+78.7%) | $7.45 M(+25.9%) |
| Sep 2022 | - | $5.92 M(+10.2%) |
| Jun 2022 | - | $5.37 M(+4.5%) |
| Mar 2022 | - | $5.14 M(+23.2%) |
| Dec 2021 | $4.17 M | $4.17 M(+86.4%) |
| Sep 2021 | - | $2.24 M(-74.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $8.79 M(+96.3%) |
| Mar 2021 | - | $4.48 M(+17.7%) |
| Dec 2020 | $3.81 M(+345.3%) | $3.81 M(+0.4%) |
| Sep 2020 | - | $3.79 M(+343.4%) |
| Dec 2019 | $854.50 K(+519.2%) | $854.50 K(+125.5%) |
| Jun 2019 | - | $379.00 K(+4.2%) |
| Mar 2019 | - | $363.60 K |
| Dec 2018 | $138.00 K(+24.0%) | - |
| Dec 2017 | $111.30 K | - |
FAQ
- What is Scopus BioPharma annual total current liabilities?
- What is the all time high annual current liabilities for Scopus BioPharma?
- What is Scopus BioPharma annual current liabilities year-on-year change?
- What is Scopus BioPharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Scopus BioPharma?
- What is Scopus BioPharma quarterly current liabilities year-on-year change?
What is Scopus BioPharma annual total current liabilities?
The current annual current liabilities of SCPS is $7.45 M
What is the all time high annual current liabilities for Scopus BioPharma?
Scopus BioPharma all-time high annual total current liabilities is $7.45 M
What is Scopus BioPharma annual current liabilities year-on-year change?
Over the past year, SCPS annual total current liabilities has changed by +$3.28 M (+78.75%)
What is Scopus BioPharma quarterly total current liabilities?
The current quarterly current liabilities of SCPS is $11.00 M
What is the all time high quarterly current liabilities for Scopus BioPharma?
Scopus BioPharma all-time high quarterly total current liabilities is $11.00 M
What is Scopus BioPharma quarterly current liabilities year-on-year change?
Over the past year, SCPS quarterly total current liabilities has changed by +$5.08 M (+85.86%)